Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Overview of preclinical and clinical evaluation of Russian nitrosourea

March 9, 1998

S-1 demonstrates excellent antitumor activity in phase II

March 9, 1998

Lilly antifolate evaluated in phase II

March 9, 1998

Favorable phase I results obtained with G-3139 in NHL

March 9, 1998

Pharmacia & Upjohn presents new tyrosine kinase inhibitors

March 6, 1998

Antitumor agents isolated from fungal strains by Roche

March 6, 1998

PKC antisense oligonucleotide shows promise in cancer therapy

March 6, 1998

Purdue discloses antitumor selenophene compounds

March 5, 1998

Colchicine analogues from Indena show potential for resistant tumors

March 5, 1998

Chemopotentiating agents in R&D at Nippon Flour Milling

March 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...